Health Economic Evaluation

Broadly speaking, the objective of universal health care systems is to maximise health gains across the general population, given a limited budget. Bodies, such as the National Institute for Health and Care Excellence (NICE) in the UK and the National Board of Health and Welfare (NBHW) in Sweden, provide guidance on decision-making on the basis of Health Technology Assessment (HTA) and cost-effectiveness analysis. These cover a collection of analytic approaches for combining costs and the consequences of interventions, such as the number of deaths or years of life lost. Interventions are compared against a control or status quo with the purpose of aiding decision-making associated with resource allocation. 

This project consists firstly of a week-long visit to Karolinska Institutet, Stockholm by Dr Green from UCL consisting of introductory training courses, lectures and meetings. It will then build on the new collaborations. Both of these courses have been delivered by Dr Green previously at his MRC-funded hackathons in London (2018) and Dublin (2019), as well as at UCL annual R in HTA workshops. In 2021, we at UCL held an online HTA in R showcase event, and over 300 people attended. A future plans meeting will be held at the end of the week to summarise and conclude the visit and more concretely record what opportunities and gaps have been identified during the visit including future training, available data, new methods, software tools, and funding opportunities.

Area

Statistical Science

UCL leads

• Dr Nathan Green, Department of Statistical Science